ASX:COH 25 April 2026 - 28 June 2026

Cochlear (ASX:COH) close to 2016 lows after FY26 loss cuts A$11.7bn
·

Cochlear (ASX:COH) close to 2016 lows after FY26 loss cuts A$11.7bn

Cochlear Limited wraps up the final ASX session of FY26 almost flat compared to FY16, even after ten years of sales gains and product launches. The hearing-implant group's shares ended Monday at A$121.08, just 17 cents under MarketIndex's close from June 30, 2016 at A$121.25. Shares remain well off the A$300.42 level seen at the end of FY25. With 65,398,917 shares outstanding, the slump from A$300.42 down to A$121.08 has cut around A$11.7 billion off the company’s equity value on a price-only basis. The company's market cap is now about A$7.9 billion, less than what the stock has lost since last June.
June 29, 2026
Cochlear shares hold steady as earnings multiple remains close to 25x
·

Cochlear shares hold steady as earnings multiple remains close to 25x

At 04:09 AEST, the ASX cash market had not yet entered pre-open. The ASX pre-open runs from 07:00 Sydney time, with normal trading from 09:59:45 to 16:00. Cochlear Limited will open the week at Friday’s close of A$118.03, after a late-week rebound. The stock’s multiple gives a clearer picture than Friday’s gain. Cochlear has climbed about one-third from its 52-week low, but its market cap remains around A$7.71 billion with a new FY26 underlying net profit forecast of A$290 million to A$330 million. The midpoint, A$310 million, puts the price at about 24.9 times earnings. That’s significant as the price already reflects a full recovery in adult and senior implant demand.
June 28, 2026
Cochlear (ASX:COH) shares trade at 25x slashed FY26 outlook after busy day
·

Cochlear (ASX:COH) shares trade at 25x slashed FY26 outlook after busy day

Cochlear Limited finished the ASX week nearly flat, but the numbers tell a choppier story. Shares slipped 0.1% over the week to A$118.03, barely changed from last Friday’s close at A$118.14. The stock dropped 4.38% on Monday and rebounded 4.5% by Friday’s finish. The S&P/ASX 200 dropped 0.7% from last Friday to this Friday, moving from 8,828.70 to 8,764.20. Cochlear managed to do a little better than the index this week, but it wasn’t by much. The stock is still working its way back after the profit warning in April.
June 26, 2026
Cochlear keeps rallying; FY26 outlook still in question
·

Cochlear keeps rallying; FY26 outlook still in question

Cochlear traded up on Wednesday, staying above A$113. The stock stretched its rebound to a seventh session after April’s earnings cut from the hearing-implant company. The stock finished the session at A$113.45, climbing 67 cents after moving between A$112.63 and A$115.13. Turnover hit 1.13 million shares, well above the recent daily average near 602,000. CSL added 2.63% and Pro Medicus rose 3.50% in Australian healthcare.
June 24, 2026
Cochlear (ASX:COH) drops 4.4% in Sydney as shorts increase
·

Cochlear (ASX:COH) drops 4.4% in Sydney as shorts increase

Cochlear Limited dropped 4.38% to A$112.97 on Monday after climbing for five straight sessions. There was no company announcement to drive the move. At press time, the ASX cash market was closed. CSL dropped 2.96%, outpacing the S&P/ASX 200’s 0.14% dip. Pro Medicus finished up 1.06%. Healthcare names ended mixed. Cochlear saw 714,600 shares traded—roughly a third of the 2.14 million seen on Friday. Lighter volumes line up with profit-taking but don’t confirm it.
June 22, 2026
Cochlear shares rally 14% in a week as rebound faces Monday test
·

Cochlear shares rally 14% in a week as rebound faces Monday test

Cochlear Limited heads into Monday’s Australian session with momentum that has been absent for much of 2026. The hearing-implant maker rose from A$103.75 on June 12 to A$118.14 on Friday, while its latest listed price-sensitive disclosure remains the April 22 trading update rather than a fresh earnings revision. That is the central issue. The rebound looks large, but it follows an almost 41% one-day collapse to a decade low after April’s profit warning. Investors are testing whether that selloff overshot the likely earnings damage; they are not responding to new operating data.
June 21, 2026
Cochlear up 14% for the week as ASX healthcare jumps
·

Cochlear up 14% for the week as ASX healthcare jumps

Cochlear Ltd shares finished up 3.37% at A$118.14 on Friday, closing out a five-day rally. The stock was at A$103.75 last week. The Australian market is shut for the weekend. Healthcare stocks outperformed on a choppy day for Australian shares. The S&P/ASX 200 fell 82.4 points to 8,828.7 in the last session. Only three sectors finished higher, with healthcare among them. CSL surged 7.62%. Cochlear saw gains as well, likely riding renewed interest in healthcare stocks that had dropped in recent weeks.
June 19, 2026
Cochlear Up 2.7% Even as ASX Falls, Profit Risks Linger
·

Cochlear Up 2.7% Even as ASX Falls, Profit Risks Linger

Cochlear Limited stock finished Thursday up 2.7% at A$114.29, tacking on A$2.97 for the day. The hearing-implant company extended its rebound even as the broader Australian market declined. The stock closed before this report’s deadline and will start Friday’s trade at that level. Cochlear is up 11.1% in the past week and nearly 27% since its April 29 low at A$90. But the stock is still down 64.2% from its July peak of A$319.42. Investors are starting to look past the shock—though not fully.
June 18, 2026
Cochlear jumps premarket after profit warning
·

Cochlear jumps premarket after profit warning

Cochlear Ltd is looking at a small bounce in Thursday’s Sydney pre-open after closing up 4.17% at A$111.32 on Wednesday. That was the hearing-implant maker’s best finish since the start of June. Cochlear is still deep in the red, despite its recent climb. The stock is off 57.35% for 2026 and trading 65.15% under its 12-month peak of A$319.42. It’s bounced 23.69% from the late-April low at A$90.00.
June 17, 2026
Cochlear jumps from decade lows following UBS target cut, FY26 outlook still a concern
·

Cochlear jumps from decade lows following UBS target cut, FY26 outlook still a concern

Cochlear Limited climbed 2.31% to A$106.86 on Tuesday, logging another session in the green. The hearing-implant stock added again, despite UBS cutting its target. Trading for Wednesday has not started. The ASX cash market runs from just before 10 a.m. to 4 p.m. Sydney time. Cochlear is still viewed as a large-cap under strain. The stock has bounced about 20% from its A$88.74 low but is down roughly 59% for the year. That’s from The Bull, citing recent broker notes.
June 16, 2026
Cochlear Stock Rallies After Harsh Profit Alert, A$100 Mark Still in Play
·

Cochlear Stock Rallies After Harsh Profit Alert, A$100 Mark Still in Play

Cochlear Ltd shares gained on Tuesday, trading above A$100. The hearing-implant maker has clawed back some ground after April's record selloff, which followed an earnings downgrade. Shares last changed hands at A$102.64 in Sydney, adding A$2.19, or 2.18%, at 4:10 p.m. The day saw around 690,000 shares traded. The stock moved between A$100.56 and A$103.75.
June 9, 2026
Cochlear Stock Rebound Faces First Big Test After ASX Holiday
·

Cochlear Stock Rebound Faces First Big Test After ASX Holiday

Cochlear shares head into Tuesday’s ASX reopening with a narrow foothold above A$100, after a late-week rebound that did little to erase investor nerves over the hearing-implant maker’s earnings reset. The ASX cash market was in pre-open in Sydney, when orders can be entered but not matched, ahead of normal trading from about 09:59:45 to 16:00 local time. Monday was not a trading day because the exchange was closed for King’s Birthday.
June 9, 2026
Cochlear Jumps; Eyes on Tuesday ASX Reopen After Pop
··

Cochlear Jumps; Eyes on Tuesday ASX Reopen After Pop

Cochlear Limited enters the holiday week at A$100.45, Friday’s last price, after shares jumped A$5.35, or 5.63%. It was one of the stronger S&P/ASX 200 performers while the index dropped 0.7% to 8,625.1. CSL, in the broader ASX healthcare group, finished up 5.75%. ASX cash trading is shut Monday for the King’s Birthday holiday on June 8. The next session opens Tuesday, giving investors a first look at whether Friday’s lift was more than just short-covering or bargain hunting.
June 7, 2026
Cochlear Stock Faces Crucial ASX Open After Post-Crash Bounce Fades
····

Cochlear Stock Faces Crucial ASX Open After Post-Crash Bounce Fades

Cochlear Ltd heads into Monday’s ASX open with little room for drift after the hearing-implant maker gave back ground last week, closing Friday at A$96.33. The shares rose 0.95% in the last session but fell 3.6% from A$99.89 a week earlier, based on historical prices. That matters now because the market is still deciding whether last month’s collapse was a clean reset or the start of a longer earnings problem. Reuters reported Cochlear shares fell 40.7% on April 22, their worst session ever, after the company slashed its annual earnings outlook on weak developed-market demand and Middle East uncertainty.
May 17, 2026
Cochlear Shares Drop Again As Investors Question the Profit Shock
····

Cochlear Shares Drop Again As Investors Question the Profit Shock

Cochlear Ltd dropped 4.64% to A$95.42 on Thursday, stretching its decline to a third straight session and leaving the Australian hearing-implant maker close to lows reached during last month’s record slide. Volume spiked, too—roughly 671,000 shares changed hands, up from 351,000 the previous day. This shift lands hard for investors still wrestling with how to value a name that used to be pegged as a reliable health-care growth play. Back on April 22, Reuters said Cochlear shares cratered 40.7%—the worst single-day performance the stock’s ever posted—after the company slashed its full-year profit outlook and pointed to sluggish demand in developed markets, Middle East unrest, and currency headwinds.
May 15, 2026
Cochlear Limited Shares Face A$100 Test After Shock Profit Cut: What Investors Watch Now
····

Cochlear Limited Shares Face A$100 Test After Shock Profit Cut: What Investors Watch Now

Sydney—May 11, 2026, 08:02 AEST Cochlear Limited will kick off trading Monday close to A$100 per share, a figure that’s become something of a litmus test for sentiment after a bruising profit warning and steep drop last month. According to MarketScreener, shares finished May 8 at A$99.89, gaining 1.7% on the session, but even after that bounce, the stock remains down 61.7% for the year.
May 11, 2026
UK & AU Stock Market Today: Live Updates 05.05.2026
······

UK & AU Stock Market Today: Live Updates 05.05.2026

LIVEMarkets rolling coverageStarted: May 5, 2026, 12:00 AM EDTUpdated: May 5, 2026, 11:59 PM EDT ANZ Banking Group Share Price Valuation: Key Metrics Explained May 5, 2026, 11:45 PM EDT. The ANZ Banking Group (ASX: ANZ) share price hovers around $37.15. Investors eyeing long-term potential can analyze workplace culture through platforms like Seek, where ANZ's rating of 3.3 outperforms the banking sector average. Profitability hinges on the net interest margin (NIM), the spread between what banks pay savers and earn from loans; ANZ's NIM of 1.57% lags behind the industry average of 1.78%, hinting at lower lending returns. The bank's
May 5, 2026
Cochlear Limited’s 42% Stock Rout Puts Monday’s ASX Open in the Spotlight After Shock Profit Cut
····

Cochlear Limited’s 42% Stock Rout Puts Monday’s ASX Open in the Spotlight After Shock Profit Cut

Cochlear Limited faces a rough start on the ASX this Monday. Shares wrapped up Friday at A$97.35—a staggering 42.21% slide over the past week—as investors continued to punish the hearing-implant maker on the heels of a major profit warning. With ASX Trade open for business Monday despite the NSW ANZAC Day public holiday, Cochlear’s performance will again be under scrutiny before normal hours kick in. The selloff stings, given Cochlear’s reputation as a defensive play in med-tech growth. That assumption’s under pressure after the latest update—turns out implant demand, notably from adults and older patients, is more sensitive to household finances, hospital bandwidth, and clinic referrals than investors seemed to expect.
April 26, 2026
Australia Stock Market This Week: ASX 200’s Worst Week Since March as Oil Shock, Fortescue Selloff Bite
·········

Australia Stock Market This Week: ASX 200’s Worst Week Since March as Oil Shock, Fortescue Selloff Bite

The S&P/ASX 200 ended Friday at 8,786.50, capping a 1.8% drop for the week—its steepest decline since mid-March—as the market struggled with Middle East jitters, a selloff in healthcare, and sliding miners. On the day, the benchmark edged down 6.9 points, or 0.08%. Miners shed 1.1%. Banks, though, eked out a late 0.3% gain. Timing is key here: the selloff landed just as investors juggled two themes—potential diplomacy efforts in the Middle East and the threat that stubbornly high oil prices could keep inflation burning. Higher crude bumps up fuel costs, can bite into company margins, and tends to firm up expectations for where interest rates might head next. The ASX’s RBA Rate Indicator shows how the market prices potential
April 25, 2026